Rentschler Biopharma
Rentschler Biopharma
Unlock Biopharma Success with Hybrid Digital Twins!
Unlock biopharma potential with hybrid digital twins! 🌐📈 Simplifying complex processes while enhancing insights for efficient production. 💡🔬 Biopharma Innovation
Rentschler Biopharma Doubles Production Capacity Making History
🏢 Rentschler Biopharma doubles cGMP capacity with new US production line, aiming to expand in complex biologics market. 🌍📈💰
Massachusetts Welcomes Fully Operational Biopharma Powerhouse
📢 Rentschler Biopharma's new production line in Massachusetts is now fully operational. 🏭 The multi-product facility doubles the company's global capacity and focuses on the commercial production of complex molecules. 🔬 The production line includes four new 2,000L single-use bioreactors and adds 22,000 square feet of cleanroom space. 🇺🇸 CEO Benedikt von Braunmühl highlights the company's strong capabilities in the US. 🚀 Rentschler Biopharma contributed to nearly 25 of FDA-approved biopharmaceuticals in 2023.
